Loading...

The current price of YI is 3.61 USD — it has increased 0 % in the last trading day.
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
Wall Street analysts forecast YI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for YI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
111 Inc revenue for the last quarter amounts to 3.85B USD, decreased -6.35 % YoY.
111 Inc. EPS for the last quarter amounts to -1.15 USD, decreased -90.71 % YoY.
111 Inc (YI) has 1238 emplpoyees as of December 15 2025.
Today YI has the market capitalization of 92.95M USD.